Medprin Regenerative Medical Technologies Balance Sheet Health
Financial Health criteria checks 5/6
Medprin Regenerative Medical Technologies has a total shareholder equity of CN¥644.6M and total debt of CN¥52.1M, which brings its debt-to-equity ratio to 8.1%. Its total assets and total liabilities are CN¥778.0M and CN¥133.5M respectively. Medprin Regenerative Medical Technologies's EBIT is CN¥54.5M making its interest coverage ratio -15.3. It has cash and short-term investments of CN¥216.2M.
Key information
8.1%
Debt to equity ratio
CN¥52.14m
Debt
Interest coverage ratio | -15.3x |
Cash | CN¥216.18m |
Equity | CN¥644.56m |
Total liabilities | CN¥133.48m |
Total assets | CN¥778.04m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301033's short term assets (CN¥265.9M) exceed its short term liabilities (CN¥47.4M).
Long Term Liabilities: 301033's short term assets (CN¥265.9M) exceed its long term liabilities (CN¥86.1M).
Debt to Equity History and Analysis
Debt Level: 301033 has more cash than its total debt.
Reducing Debt: 301033's debt to equity ratio has increased from 0% to 8.1% over the past 5 years.
Debt Coverage: 301033's debt is well covered by operating cash flow (199.7%).
Interest Coverage: 301033 earns more interest than it pays, so coverage of interest payments is not a concern.